Latest News and Press Releases

For immediate release iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials Analysis provides further validation of MINIject®’s meaningful and...

For immediate release iSTAR Medical Expands Commercial Rollout with First MINIject® Surgeries in Switzerland The only commercially available MIGS device currently targeting the supraciliary...

For immediate release iSTAR Medical Continues Market Expansion with First MINIject® Surgeries in the UK UK patients and surgeons now able to benefit from the only commercially available MIGS device...

For immediate release iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject Pivotal trial of MINIject, STAR-V, now initiated in 13 sites across the USPositive feedback from...

For immediate release iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject Pivotal trial of MINIject, STAR-V, now initiated in 13 sites across the USPositive feedback from...

iSTAR Medical receives European market approval for glaucoma implant MINIject The only commercially available, minimally invasive supraciliary device for glaucoma now approved First commercial...

Para publicación inmediata iSTAR Medical recibe la aprobación de comercialización en Europa para el implante para glaucoma MINIject El único dispositivo supraciliar mínimamente invasivo...

Voor onmiddellijke publicatie iSTAR Medical krijgt goedkeuring voor de Europese markt voor het glaucoomimplantaat MINIject Het enige commercieel verkrijgbare, minimaal invasieve supraciliaire...

Zur sofortigen Freigabe iSTAR Medical erhält europäische Marktzulassung für Glaukom-Implantat MINIject Das einzige kommerziell verfügbare, minimalinvasive supraziliäre Implantat für Glaukom jetzt...

iSTAR Medical receives European market approval for glaucoma implant MINIject The only commercially available, minimally invasive supraciliary device for glaucoma now approved First commercial...